Blencowe Resources: Aspiring to become one of the largest graphite producers in the world. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPlant Health Regulatory News (PHC)

Share Price Information for Plant Health (PHC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4.20
Bid: 4.20
Ask: 4.40
Change: -0.35 (-7.69%)
Spread: 0.20 (4.762%)
Open: 4.32
High: 4.32
Low: 4.20
Prev. Close: 4.55
PHC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

PHC and Arysta LifeScience Terminate Agreement

30 Nov 2015 07:00

RNS Number : 9951G
Plant Health Care PLC
30 November 2015
 

Plant Health Care and Arysta LifeScience Announce Termination of Combination Products Agreement

 

Raleigh / Cary, NC, November 30, 2015. Plant Health Care, Inc., a leading supplier of novel patent-protected biological products, and Arysta LifeScience, a leading crop protection and life science company, have mutually agreed to terminate the product development and license agreement enabling Arysta LifeScience to sell combination products containing Plant Health Care's Harpin

𝜶β protein technology combined with Arysta LifeScience's crop protection products in the U.S. row crop market.

 

Challenging conditions in agricultural markets driven by weak crop prices, especially in row crops, coupled with focus on the organizational merger of Chemtura AgroSolutions, Agriphar and Arysta LifeScience contributed to an unsuccessful launch of the first combination product under the agreement.

 

Plant Health Care will now have enhanced flexibility to deploy their resources toward opportunities in high-value specialty crops while accessing row crop markets in the U.S. with Harpin 𝜶β as both a straight product and in combination with mixture partners. Arysta LifeScience, now owned by Platform Specialty Products, will continue to offer a range of crop protection products including fungicides for both seed treatment and foliar application in row crop markets.

 

The companies continue to work together to bring Plant Health Care's technology to market in Brazil through foliar applications on sugarcane and to seek other opportunities for global collaboration.

 

About Plant Health Care: Plant Health Care is a leading provider of novel patent-protected biological products to the global agriculture markets. In this way, Plant Health Care is capitalising on long-term trends toward natural systems and biological products for plant care and soil and water management. The Company's ordinary shares have been quoted on the AIM market of the London Stock Exchange since July 2004 (ticker symbol: PHC). More information on the company is available at www.planthealthcare.com

 

About Arysta LifeScience Limited

Arysta LifeScience, now owned by Platform Specialty Products, is a leading crop protection and life science company with 2014 revenues of US $2.2 billion. An entrepreneurial provider of crop protection and life science products in more than 125 countries worldwide, Arysta LifeScience specializes in marketing and distribution of respected crop protection brands and life science products that meet the needs of its global partners. More information on the company is available at www.arystalifescience.com.

 

For further information, please contact:

 

Plant Health Care plc

Jeff Tweedy, Head of Commercial Operations Tel: +1 (919) 926 1600

 

Arysta LifeScience

Linda Frerichs, Global & North America Communications Tel: +1 (919) 678-4948

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGRFESFUIFISEDF
Date   Source Headline
8th May 20247:00 amRNSTrading Update
22nd Apr 20247:00 amRNSApproval of Harpinαβ in Belgium
16th Apr 20247:00 amRNSPlant Health Care--China Distribution with AMVAC
4th Apr 20247:00 amRNSApproval of PHC68949 in Mexico
4th Mar 20241:55 pmRNSHolding(s) in Company
24th Jan 20244:27 pmRNSHolding(s) in Company
2nd Jan 20247:00 amRNSBrazil approves TEIKKOâ„¢
20th Dec 20237:00 amRNSBoard Changes and Grant of Options
19th Dec 20233:34 pmRNSHolding(s) in Company
30th Nov 20231:45 pmRNSHolding(s) in Company
28th Nov 20233:16 pmRNSHolding(s) in Company
27th Nov 20234:03 pmRNSHolding(s) in Company
27th Nov 20231:27 pmRNSHolding(s) in Company
24th Nov 20234:19 pmRNSDirector/PDMR Shareholding
24th Nov 202310:57 amRNSDirector/PDMR Shareholding
23rd Nov 20232:31 pmRNSHolding(s) in Company
22nd Nov 20237:00 amRNSTrading Update
31st Oct 20237:00 amRNSChange of Adviser
20th Oct 20237:00 amRNSHolding(s) in Company
3rd Oct 20236:28 pmRNSPlant Health Care PREtec Product with Agrii UK
28th Sep 20237:00 amRNSNew PREtec Products Announced
27th Sep 20237:00 amRNSUnaudited Interim Results
25th Sep 20237:00 amRNSPREtec Products Submitted for Regulatory Approval
31st Aug 20237:00 amRNSNotice of Results & Investor Presentation
18th Aug 20237:00 amRNSNew Product Regulatory Approval In Brazil
1st Aug 20237:00 amRNSApproval for Sale of Harpin aß Granted in Poland
24th Jul 20237:00 amRNSGrant of Options
12th Jul 202312:27 pmRNSHolding(s) in Company
30th Jun 20235:07 pmRNSNotification of Major Holdings
28th Jun 202312:29 pmRNSHolding(s) in Company
27th Jun 20234:08 pmRNSHolding(s) in Company
27th Jun 20231:08 pmRNSDirector Shareholding
23rd Jun 20237:00 amRNSResult of Fundraising
22nd Jun 20234:35 pmRNSFundraising to raise up to US$3.6 million
14th Jun 20237:00 amRNSWilbur Ellis Agreement
13th Jun 20231:43 pmRNSResult of AGM
30th May 20237:00 amRNSHolding(s) in Company
24th May 20231:12 pmRNSHolding(s) in Company
19th May 20235:55 pmRNSPublication of Annual Report and Notice of AGM
18th May 20237:00 amRNSResult of Consultation
9th May 20237:00 amRNSPHC68949 granted first stage of approval in Brazil
2nd May 20237:10 amRNSResults for the year ended 31 December 2022
12th Apr 20232:33 pmRNSNotice of Results
5th Apr 20235:29 pmRNSHolding(s) in Company
8th Mar 20232:45 pmRNSExercise of Options
2nd Mar 20237:00 amRNSBiofungicide PHC279 Approved by US EPA
1st Mar 20237:00 amRNSDirector/PDMR Shareholding
6th Feb 20237:00 amRNSTrading Statement
30th Jan 202312:08 pmRNSSignificant Shareholder
18th Jan 20237:00 amRNSBoard Appointments

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.